Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 90

1.

The role of blood pressure in risk of ischemic and hemorrhagic stroke in type 1 diabetes.

Hägg-Holmberg S, Dahlström EH, Forsblom CM, Harjutsalo V, Liebkind R, Putaala J, Tatlisumak T, Groop PH, Thorn LM; FinnDiane Study Group.

Cardiovasc Diabetol. 2019 Jul 9;18(1):88. doi: 10.1186/s12933-019-0891-4.

PMID:
31288813
Free Article
2.

Dietary intake in type 1 diabetes at different stages of diabetic kidney disease.

Ahola AJ, Forsblom C, Harjutsalo V, Groop PH.

Diabetes Res Clin Pract. 2019 Jul 1. pii: S0168-8227(19)30243-8. doi: 10.1016/j.diabres.2019.06.016. [Epub ahead of print]

PMID:
31271811
3.

Insulin exposure mitigates the increase of arterial stiffness in patients with type 2 diabetes and albuminuria: an exploratory analysis.

Gordin D, Saraheimo M, Tuomikangas J, Soro-Paavonen A, Forsblom C, Paavonen K, Steckel-Hamann B, Harjutsalo V, Nicolaou L, Pavo I, Koivisto V, Groop PH.

Acta Diabetol. 2019 May 22. doi: 10.1007/s00592-019-01351-4. [Epub ahead of print]

PMID:
31119456
4.

Body mass index and mortality in individuals with type 1 diabetes.

Dahlström EH, Sandholm N, Forsblom CM, Thorn LM, Jansson FJ, Harjutsalo V, Groop PH; FinnDiane Study Group.

J Clin Endocrinol Metab. 2019 Apr 29. pii: jc.2019-00042. doi: 10.1210/jc.2019-00042. [Epub ahead of print]

PMID:
31034018
5.
6.

Genetic Determinants of Glycated Hemoglobin in Type 1 Diabetes.

Syreeni A, Sandholm N, Cao J, Toppila I, Maahs DM, Rewers MJ, Snell-Bergeon JK, Costacou T, Orchard TJ, Caramori ML, Mauer M, Klein BEK, Klein R, Valo E, Parkkonen M, Forsblom C, Harjutsalo V, Paterson AD; DCCT/EDIC Research Group, Groop PH; FinnDiane Study Group.

Diabetes. 2019 Apr;68(4):858-867. doi: 10.2337/db18-0573. Epub 2019 Jan 23.

PMID:
30674623
7.

Trends and cyclical variation in the incidence of childhood type 1 diabetes in 26 European centres in the 25 year period 1989-2013: a multicentre prospective registration study.

Patterson CC, Harjutsalo V, Rosenbauer J, Neu A, Cinek O, Skrivarhaug T, Rami-Merhar B, Soltesz G, Svensson J, Parslow RC, Castell C, Schoenle EJ, Bingley PJ, Dahlquist G, Jarosz-Chobot PK, Marčiulionytė D, Roche EF, Rothe U, Bratina N, Ionescu-Tirgoviste C, Weets I, Kocova M, Cherubini V, Rojnic Putarek N, deBeaufort CE, Samardzic M, Green A.

Diabetologia. 2019 Mar;62(3):408-417. doi: 10.1007/s00125-018-4763-3. Epub 2018 Nov 28.

8.

Variations in Risk of End-Stage Renal Disease and Risk of Mortality in an International Study of Patients With Type 1 Diabetes and Advanced Nephropathy.

Skupien J, Smiles AM, Valo E, Ahluwalia TS, Gyorgy B, Sandholm N, Croall S, Lajer M, McDonnell K, Forsblom C, Harjutsalo V, Marre M, Galecki AT, Tregouet DA, Wu CY, Mychaleckyj JC, Nickerson H, Pragnell M, Rich SS, Pezzolesi MG, Hadjadj S, Rossing P, Groop PH, Krolewski AS.

Diabetes Care. 2019 Jan;42(1):93-101. doi: 10.2337/dc18-1369. Epub 2018 Nov 19.

PMID:
30455333
9.

Associations of dietary macronutrient and fibre intake with glycaemia in individuals with Type 1 diabetes.

Ahola AJ, Harjutsalo V, Forsblom C, Saraheimo M, Groop PH; Finnish Diabetic Nephropathy Study.

Diabet Med. 2018 Nov 13. doi: 10.1111/dme.13863. [Epub ahead of print]

PMID:
30426566
10.

Long-term Mortality After Kidney Transplantation in a Nationwide Cohort of Patients With Type 1 Diabetes in Finland.

Ortiz F, Harjutsalo V, Helanterä I, Lempinen M, Forsblom C, Groop PH.

Diabetes Care. 2019 Jan;42(1):55-61. doi: 10.2337/dc18-1029. Epub 2018 Nov 2.

PMID:
30389672
11.

The Association of Severe Diabetic Retinopathy With Cardiovascular Outcomes in Long-standing Type 1 Diabetes: A Longitudinal Follow-up.

Pongrac Barlovic D, Harjutsalo V, Gordin D, Kallio M, Forsblom C, King G, Groop PH; FinnDiane Study Group.

Diabetes Care. 2018 Dec;41(12):2487-2494. doi: 10.2337/dc18-0476. Epub 2018 Sep 26.

PMID:
30257963
12.

Dose-dependent effect of smoking on risk of coronary heart disease, heart failure and stroke in individuals with type 1 diabetes.

Feodoroff M, Harjutsalo V, Forsblom C, Groop PH; FinnDiane Study Group.

Diabetologia. 2018 Dec;61(12):2580-2589. doi: 10.1007/s00125-018-4725-9. Epub 2018 Sep 18.

PMID:
30229273
13.

Confirmation of GLRA3 as a susceptibility locus for albuminuria in Finnish patients with type 1 diabetes.

Sandholm N, Haukka JK, Toppila I, Valo E, Harjutsalo V, Forsblom C, Groop PH.

Sci Rep. 2018 Aug 17;8(1):12408. doi: 10.1038/s41598-018-29211-1.

14.

Risk of coronary artery disease and stroke according to sex and presence of diabetic nephropathy in type 1 diabetes.

Harjutsalo V, Thomas MC, Forsblom C, Groop PH; FinnDiane Study Group.

Diabetes Obes Metab. 2018 Dec;20(12):2759-2767. doi: 10.1111/dom.13456. Epub 2018 Aug 7.

PMID:
29962015
15.

Ambulatory blood pressure and arterial stiffness in individuals with type 1 diabetes.

Lithovius R, Gordin D, Forsblom C, Saraheimo M, Harjutsalo V, Groop PH; FinnDiane Study Group.

Diabetologia. 2018 Sep;61(9):1935-1945. doi: 10.1007/s00125-018-4648-5. Epub 2018 May 24.

PMID:
29797021
16.

A Genome-Wide Association Study of Diabetic Kidney Disease in Subjects With Type 2 Diabetes.

van Zuydam NR, Ahlqvist E, Sandholm N, Deshmukh H, Rayner NW, Abdalla M, Ladenvall C, Ziemek D, Fauman E, Robertson NR, McKeigue PM, Valo E, Forsblom C, Harjutsalo V; Finnish Diabetic Nephropathy Study (FinnDiane), Perna A, Rurali E, Marcovecchio ML, Igo RP Jr, Salem RM, Perico N, Lajer M, Käräjämäki A, Imamura M, Kubo M, Takahashi A, Sim X, Liu J, van Dam RM, Jiang G, Tam CHT, Luk AOY, Lee HM, Lim CKP, Szeto CC, So WY, Chan JCN; Hong Kong Diabetes Registry Theme-based Research Scheme Project Group, Ang SF, Dorajoo R, Wang L, Clara TSH, McKnight AJ, Duffy S; Warren 3 and Genetics of Kidneys in Diabetes (GoKinD) Study Group, Pezzolesi MG; GENIE (GEnetics of Nephropathy an International Effort) Consortium, Marre M, Gyorgy B, Hadjadj S, Hiraki LT; Diabetes Control and Complications Trial (DCCT)/Epidemiology of Diabetes Interventions and Complications (EDIC) Research Group, Ahluwalia TS, Almgren P, Schulz CA, Orho-Melander M, Linneberg A, Christensen C, Witte DR, Grarup N, Brandslund I, Melander O, Paterson AD, Tregouet D, Maxwell AP, Lim SC, Ma RCW, Tai ES, Maeda S, Lyssenko V, Tuomi T, Krolewski AS, Rich SS, Hirschhorn JN, Florez JC, Dunger D, Pedersen O, Hansen T, Rossing P, Remuzzi G; SUrrogate markers for Micro- and Macrovascular hard endpoints for Innovative diabetes Tools (SUMMIT) Consortium, Brosnan MJ, Palmer CNA, Groop PH, Colhoun HM, Groop LC, McCarthy MI.

Diabetes. 2018 Jul;67(7):1414-1427. doi: 10.2337/db17-0914. Epub 2018 Apr 27.

17.

Association between habitual coffee consumption and metabolic syndrome in type 1 diabetes.

Stutz B, Ahola AJ, Harjutsalo V, Forsblom C, Groop PH; FinnDiane Study Group.

Nutr Metab Cardiovasc Dis. 2018 May;28(5):470-476. doi: 10.1016/j.numecd.2018.01.011. Epub 2018 Feb 1.

PMID:
29501444
18.

Regression of albuminuria and its association with incident cardiovascular outcomes and mortality in type 1 diabetes: the FinnDiane Study.

Jansson FJ, Forsblom C, Harjutsalo V, Thorn LM, Wadén J, Elonen N, Ahola AJ, Saraheimo M, Groop PH; FinnDiane Study Group.

Diabetologia. 2018 May;61(5):1203-1211. doi: 10.1007/s00125-018-4564-8. Epub 2018 Feb 8.

PMID:
29423580
19.

Differential Association of Microvascular Attributions With Cardiovascular Disease in Patients With Long Duration of Type 1 Diabetes.

Gordin D, Harjutsalo V, Tinsley L, Fickweiler W, Sun JK, Forsblom C, Amenta PS, Pober D, D'Eon S, Khatri M, Stillman IE, Groop PH, Keenan HA, King GL.

Diabetes Care. 2018 Apr;41(4):815-822. doi: 10.2337/dc17-2250. Epub 2018 Jan 31.

20.

Excess Mortality in Patients With Type 1 Diabetes Without Albuminuria-Separating the Contribution of Early and Late Risks.

Groop PH, Thomas M, Feodoroff M, Forsblom C, Harjutsalo V; FinnDiane Study Group.

Diabetes Care. 2018 Apr;41(4):748-754. doi: 10.2337/dc17-1618. Epub 2018 Jan 29.

PMID:
29378776
21.

Incidence of End-Stage Renal Disease in Patients With Type 1 Diabetes.

Helve J, Sund R, Arffman M, Harjutsalo V, Groop PH, Grönhagen-Riska C, Finne P.

Diabetes Care. 2018 Mar;41(3):434-439. doi: 10.2337/dc17-2364. Epub 2017 Dec 20.

PMID:
29263163
22.

Physical Activity Reduces Risk of Premature Mortality in Patients With Type 1 Diabetes With and Without Kidney Disease.

Tikkanen-Dolenc H, Wadén J, Forsblom C, Harjutsalo V, Thorn LM, Saraheimo M, Elonen N, Tikkanen HO, Groop PH; FinnDiane Study Group.

Diabetes Care. 2017 Dec;40(12):1727-1732. doi: 10.2337/dc17-0615. Epub 2017 Oct 16.

PMID:
29038314
23.

Genetic determinants of serum 25-hydroxyvitamin D concentration during pregnancy and type 1 diabetes in the child.

Miettinen ME, Smart MC, Kinnunen L, Harjutsalo V, Reinert-Hartwall L, Ylivinkka I, Surcel HM, Lamberg-Allardt C, Hitman GA, Tuomilehto J.

PLoS One. 2017 Oct 4;12(10):e0184942. doi: 10.1371/journal.pone.0184942. eCollection 2017.

24.

Prognosis and Its Predictors After Incident Stroke in Patients With Type 1 Diabetes.

Hägg-Holmberg S, Thorn LM, Forsblom CM, Gordin D, Elonen N, Harjutsalo V, Liebkind R, Putaala J, Tatlisumak T, Groop PH; FinnDiane Study Group.

Diabetes Care. 2017 Oct;40(10):1394-1400. doi: 10.2337/dc17-0681. Epub 2017 Aug 15.

PMID:
28811283
25.

Dietary patterns reflecting healthy food choices are associated with lower serum LPS activity.

Ahola AJ, Lassenius MI, Forsblom C, Harjutsalo V, Lehto M, Groop PH.

Sci Rep. 2017 Jul 26;7(1):6511. doi: 10.1038/s41598-017-06885-7.

26.

Data-driven metabolic subtypes predict future adverse events in individuals with type 1 diabetes.

Lithovius R, Toppila I, Harjutsalo V, Forsblom C, Groop PH, Mäkinen VP; FinnDiane Study Group.

Diabetologia. 2017 Jul;60(7):1234-1243. doi: 10.1007/s00125-017-4273-8. Epub 2017 Apr 24.

PMID:
28439641
27.

The serum uric acid concentration is not causally linked to diabetic nephropathy in type 1 diabetes.

Ahola AJ, Sandholm N, Forsblom C, Harjutsalo V, Dahlström E, Groop PH; FinnDiane Study Group.

Kidney Int. 2017 May;91(5):1178-1185. doi: 10.1016/j.kint.2016.11.025. Epub 2017 Feb 21.

PMID:
28238338
28.

The association between macronutrient intake and the metabolic syndrome and its components in type 1 diabetes.

Ahola AJ, Harjutsalo V, Thorn LM, Freese R, Forsblom C, Mäkimattila S, Groop PH.

Br J Nutr. 2017 Feb;117(3):450-456. doi: 10.1017/S0007114517000198. Epub 2017 Feb 20.

PMID:
28215203
29.

Frequent and intensive physical activity reduces risk of cardiovascular events in type 1 diabetes.

Tikkanen-Dolenc H, Wadén J, Forsblom C, Harjutsalo V, Thorn LM, Saraheimo M, Elonen N, Rosengård-Bärlund M, Gordin D, Tikkanen HO, Groop PH; FinnDiane Study Group.

Diabetologia. 2017 Mar;60(3):574-580. doi: 10.1007/s00125-016-4189-8. Epub 2016 Dec 24.

PMID:
28013340
30.

Endotoxins are associated with visceral fat mass in type 1 diabetes.

Lassenius MI, Ahola AJ, Harjutsalo V, Forsblom C, Groop PH, Lehto M.

Sci Rep. 2016 Dec 13;6:38887. doi: 10.1038/srep38887.

31.

The Genetic Landscape of Renal Complications in Type 1 Diabetes.

Sandholm N, Van Zuydam N, Ahlqvist E, Juliusdottir T, Deshmukh HA, Rayner NW, Di Camillo B, Forsblom C, Fadista J, Ziemek D, Salem RM, Hiraki LT, Pezzolesi M, Trégouët D, Dahlström E, Valo E, Oskolkov N, Ladenvall C, Marcovecchio ML, Cooper J, Sambo F, Malovini A, Manfrini M, McKnight AJ, Lajer M, Harjutsalo V, Gordin D, Parkkonen M; The FinnDiane Study Group, Tuomilehto J, Lyssenko V, McKeigue PM, Rich SS, Brosnan MJ, Fauman E, Bellazzi R, Rossing P, Hadjadj S, Krolewski A, Paterson AD; The DCCT/EDIC Study Group, Florez JC, Hirschhorn JN, Maxwell AP; GENIE Consortium, Dunger D, Cobelli C, Colhoun HM, Groop L, McCarthy MI, Groop PH; SUMMIT Consortium.

J Am Soc Nephrol. 2017 Feb;28(2):557-574. doi: 10.1681/ASN.2016020231. Epub 2016 Sep 19.

32.

Association of serum 25-hydroxyvitamin D concentration with HLA-B, -DRB1 and -DQB1 genetic polymorphisms.

Miettinen ME, Kinnunen L, Harjutsalo V, Aimonen K, Surcel HM, Lamberg-Allardt C, Tuomilehto J.

Eur J Clin Nutr. 2017 Jan;71(1):128-131. doi: 10.1038/ejcn.2016.160. Epub 2016 Sep 14.

PMID:
27623983
33.

Variation in SLC19A3 and Protection From Microvascular Damage in Type 1 Diabetes.

Porta M, Toppila I, Sandholm N, Hosseini SM, Forsblom C, Hietala K, Borio L, Harjutsalo V, Klein BE, Klein R, Paterson AD; DCCT/EDIC Research Group, Groop PH; FinnDiane Study Group.

Diabetes. 2016 Apr;65(4):1022-30. doi: 10.2337/db15-1247. Epub 2015 Dec 30.

34.

Smoking and progression of diabetic nephropathy in patients with type 1 diabetes.

Feodoroff M, Harjutsalo V, Forsblom C, Thorn L, Wadén J, Tolonen N, Lithovius R, Groop PH.

Acta Diabetol. 2016 Aug;53(4):525-33. doi: 10.1007/s00592-015-0822-0. Epub 2015 Dec 14.

PMID:
26668013
35.

Age at menarche and the risk of diabetic microvascular complications in patients with type 1 diabetes.

Harjutsalo V, Maric-Bilkan C, Forsblom C, Groop PH; FinnDiane Study Group.

Diabetologia. 2016 Mar;59(3):472-80. doi: 10.1007/s00125-015-3816-0. Epub 2015 Nov 25.

PMID:
26607636
36.

The impact of smoking on the effect of the rs4972593 genetic variant on end-stage renal disease.

Feodoroff M, Harjutsalo V, Forsblom C, Sandholm N, Groop PH; FinnDiane Study Group.

Diabet Med. 2016 Sep;33(9):1301-3. doi: 10.1111/dme.13027. No abstract available.

PMID:
26535560
37.

The Presence and Consequence of Nonalbuminuric Chronic Kidney Disease in Patients With Type 1 Diabetes.

Thorn LM, Gordin D, Harjutsalo V, Hägg S, Masar R, Saraheimo M, Tolonen N, Wadén J, Groop PH, Forsblom CM; FinnDiane Study Group.

Diabetes Care. 2015 Nov;38(11):2128-33. doi: 10.2337/dc15-0641. Epub 2015 Aug 26.

PMID:
26310691
38.

Maternal VDR variants rather than 25-hydroxyvitamin D concentration during early pregnancy are associated with type 1 diabetes in the offspring.

Miettinen ME, Smart MC, Kinnunen L, Mathews C, Harjutsalo V, Surcel HM, Lamberg-Allardt C, Tuomilehto J, Hitman GA.

Diabetologia. 2015 Oct;58(10):2278-83. doi: 10.1007/s00125-015-3675-8. Epub 2015 Jun 26.

PMID:
26109216
39.

Kidney injury molecule-1 and the loss of kidney function in diabetic nephropathy: a likely causal link in patients with type 1 diabetes.

Panduru NM, Sandholm N, Forsblom C, Saraheimo M, Dahlström EH, Thorn LM, Gordin D, Tolonen N, Wadén J, Harjutsalo V, Bierhaus A, Humpert PM, Groop PH; FinnDiane Study Group.

Diabetes Care. 2015 Jun;38(6):1130-7. doi: 10.2337/dc14-2330. Epub 2015 Mar 17.

PMID:
25784666
40.

Bacterial infections in patients with type 1 diabetes: a 14-year follow-up study.

Simonsen JR, Harjutsalo V, Järvinen A, Kirveskari J, Forsblom C, Groop PH, Lehto M; FinnDiane Study Group.

BMJ Open Diabetes Res Care. 2015 Mar 5;3(1):e000067. doi: 10.1136/bmjdrc-2014-000067. eCollection 2015.

41.

Leisure-time physical activity and development and progression of diabetic nephropathy in type 1 diabetes: the FinnDiane Study.

Wadén J, Tikkanen HK, Forsblom C, Harjutsalo V, Thorn LM, Saraheimo M, Tolonen N, Rosengård-Bärlund M, Gordin D, Tikkanen HO, Groop PH; FinnDiane Study Group.

Diabetologia. 2015 May;58(5):929-36. doi: 10.1007/s00125-015-3499-6. Epub 2015 Jan 30.

PMID:
25634228
42.

Predicting major outcomes in type 1 diabetes: a model development and validation study.

Soedamah-Muthu SS, Vergouwe Y, Costacou T, Miller RG, Zgibor J, Chaturvedi N, Snell-Bergeon JK, Maahs DM, Rewers M, Forsblom C, Harjutsalo V, Groop PH, Fuller JH, Moons KG, Orchard TJ.

Diabetologia. 2014 Nov;57(11):2304-14. doi: 10.1007/s00125-014-3358-x. Epub 2014 Sep 4.

43.

[Who will develop diabetic nephropathy?].

Forsblom C, Harjutsalo V, Groop PH.

Duodecim. 2014;130(12):1253-9. Review. Finnish.

PMID:
25016671
44.

Osteopontin is a strong predictor of incipient diabetic nephropathy, cardiovascular disease, and all-cause mortality in patients with type 1 diabetes.

Gordin D, Forsblom C, Panduru NM, Thomas MC, Bjerre M, Soro-Paavonen A, Tolonen N, Sandholm N, Flyvbjerg A, Harjutsalo V, Groop PH; FinnDiane Study Group.

Diabetes Care. 2014 Sep;37(9):2593-600. doi: 10.2337/dc14-0065. Epub 2014 Jun 26.

PMID:
24969575
45.

Different lipid variables predict incident coronary artery disease in patients with type 1 diabetes with or without diabetic nephropathy: the FinnDiane study.

Tolonen N, Forsblom C, Mäkinen VP, Harjutsalo V, Gordin D, Feodoroff M, Sandholm N, Thorn LM, Wadén J, Taskinen MR, Groop PH; FinnDiane Study Group.

Diabetes Care. 2014 Aug;37(8):2374-82. doi: 10.2337/dc13-2873. Epub 2014 May 30.

PMID:
24879842
46.

Added value of soluble tumor necrosis factor-α receptor 1 as a biomarker of ESRD risk in patients with type 1 diabetes.

Forsblom C, Moran J, Harjutsalo V, Loughman T, Wadén J, Tolonen N, Thorn L, Saraheimo M, Gordin D, Groop PH, Thomas MC; FinnDiane Study Group.

Diabetes Care. 2014 Aug;37(8):2334-42. doi: 10.2337/dc14-0225. Epub 2014 May 30.

PMID:
24879837
47.

Novel genetic susceptibility loci for diabetic end-stage renal disease identified through robust naive Bayes classification.

Sambo F, Malovini A, Sandholm N, Stavarachi M, Forsblom C, Mäkinen VP, Harjutsalo V, Lithovius R, Gordin D, Parkkonen M, Saraheimo M, Thorn LM, Tolonen N, Wadén J, He B, Osterholm AM, Tuomilehto J, Lajer M, Salem RM, McKnight AJ; GENIE Consortium, Tarnow L, Panduru NM, Barbarini N, Di Camillo B, Toffolo GM, Tryggvason K, Bellazzi R, Cobelli C; FinnDiane Study Group, Groop PH.

Diabetologia. 2014 Aug;57(8):1611-22. doi: 10.1007/s00125-014-3256-2. Epub 2014 May 29.

PMID:
24871321
48.

The consequences of failure to achieve targets of guidelines for prevention and treatment of diabetic complications in patients with type 1 diabetes.

Lithovius R, Harjutsalo V, Forsblom C, Saraheimo M, Groop PH.

Acta Diabetol. 2015 Feb;52(1):31-8. doi: 10.1007/s00592-014-0595-x. Epub 2014 May 22.

PMID:
24849006
49.

Epidemiology and risk factors for diabetic kidney disease.

Harjutsalo V, Groop PH.

Adv Chronic Kidney Dis. 2014 May;21(3):260-6. doi: 10.1053/j.ackd.2014.03.009. Review.

PMID:
24780453
50.

Genome-wide association study of urinary albumin excretion rate in patients with type 1 diabetes.

Sandholm N, Forsblom C, Mäkinen VP, McKnight AJ, Osterholm AM, He B, Harjutsalo V, Lithovius R, Gordin D, Parkkonen M, Saraheimo M, Thorn LM, Tolonen N, Wadén J, Tuomilehto J, Lajer M, Ahlqvist E, Möllsten A, Marcovecchio ML, Cooper J, Dunger D, Paterson AD, Zerbini G, Groop L; SUMMIT Consortium, Tarnow L, Maxwell AP, Tryggvason K, Groop PH; FinnDiane Study Group.

Diabetologia. 2014 Jun;57(6):1143-53. doi: 10.1007/s00125-014-3202-3. Epub 2014 Mar 5.

PMID:
24595857

Supplemental Content

Loading ...
Support Center